Children's Oncology Group

NCT07466316

Phase 3Recruiting2026342 people12 Mar 2026clinicaltrials.gov

NCT07072585

Phase 2/3Not yet recruiting20261,708 people18 Jul 2025clinicaltrials.gov

Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body

Phase 2/3Terminated20252 people11 Feb 2025clinicaltrials.gov

NCT06647953

Phase 3Recruiting2025110 people18 Oct 2024clinicaltrials.gov

NCT06401330

Phase 3Recruiting20251,656 people6 May 2024clinicaltrials.gov

NCT05382338

Phase 3Recruiting2023225 people19 May 2022clinicaltrials.gov

NCT05304585

Phase 3Recruiting2022205 people31 Mar 2022clinicaltrials.gov

NCT04994132

Phase 3Active, not recruiting2021113 people6 Aug 2021clinicaltrials.gov

NCT04939597

Phase 3Active, not recruiting2022162 people25 Jun 2021clinicaltrials.gov

NCT04322318

Phase 2Recruiting2020256 people26 Mar 2020clinicaltrials.gov

NCT04293562

Phase 3Recruiting20201,400 people3 Mar 2020clinicaltrials.gov

NCT03959085

Phase 3Recruiting20195,951 people22 May 2019clinicaltrials.gov

NCT03792256

Phase 1Completed201912 people3 Jan 2019clinicaltrials.gov

NCT03533582

Phase 3Active, not recruiting2018537 people23 May 2018clinicaltrials.gov

NCT03126916

Phase 3Recruiting2018750 people25 Apr 2017clinicaltrials.gov

NCT03067181

Phase 3Recruiting20171,780 people1 Mar 2017clinicaltrials.gov

NCT03057054

Phase 3Active, not recruiting2018173 people17 Feb 2017clinicaltrials.gov

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Phase 3Active, not recruiting2017352 people2 Jan 2017clinicaltrials.gov

NCT02975882

Phase 1Completed201733 people29 Nov 2016clinicaltrials.gov

NCT02724579

Phase 2Active, not recruiting201745 people31 Mar 2016clinicaltrials.gov